Q: What is Fintepla used for?

Fintepla is used to treat Dravet syndrome and Lennox-Gastaut syndrome .

Q: How does Fintepla work?

Mechanism of Action Fintepla belongs to a class of medications known as anticonvulsants. While the exact way it works to control seizures is not fully understood, researchers believe it primarily affects chemical signaling in the brain. Serotonin Regulation One of the main ways Fintepla is thought to work is by increasing the levels and activity of serotonin. Serotonin is a natural substance, or neurotransmitter, that helps brain cells communicate. Fintepla acts as a serotonin receptor agonist, which means it stimulates specific receptors in the brain that respond to serotonin. This increased activity is believed to help regulate the electrical signals that can lead to seizures. Sigma-1 Receptors In addition to its effects on serotonin, Fintepla may also interact with sigma-1 receptors. These receptors play a role in how nerve cells function and communicate with one another. By acting on these pathways, the medication helps stabilize brain activity. By influencing these different chemical systems, Fintepla helps to decrease the frequency of seizures in people with certain types of epilepsy, such as Dravet syndrome and Lennox-Gastaut syndrome.

Q: What are the active ingredients in Fintepla?

The active ingredient in Fintepla is fenfluramine .

Q: What are the side effects of Fintepla?

Common side effects of Fintepla may include: Decreased appetite Diarrhea Fatigue and others. Always consult with a healthcare professional about potential side effects.

Q: What drug class is Fintepla?

Fintepla belongs to the serotonin releasing agent drug class.

Q: What is the dosage of Fintepla and how do I take it?

How to Take Fintepla Fintepla is an oral solution that is usually taken twice a day. It can be taken with or without food. Administration Instructions Measuring the Dose: Always use the oral dosing syringe provided with the medication to ensure the dose is measured accurately. Do not use household spoons or other kitchen measuring tools, as they may not provide the correct amount. Feeding Tubes: This medication can be administered through certain types of gastric or enteral feeding tubes. If using a tube, it should be flushed with water after the dose is given to ensure all the medicine has been delivered. Consistency: Try to take the medication at the same times every day to maintain a steady level of the drug in the body. Missed Doses If a dose of Fintepla is missed, skip that dose and take the next dose at the regularly scheduled time. Do not take two doses at once to make up for a missed dose.

Q: Is Fintepla safe during pregnancy and breastfeeding?

Pregnancy The safety of Fintepla during pregnancy has not been established. While animal studies have suggested potential risks to a developing fetus, there is currently no adequate data on its effects in pregnant humans. Individuals who are pregnant or planning to become pregnant should consult their healthcare provider to weigh the potential benefits against the risks. There is a pregnancy registry for people who take Fintepla during pregnancy. This registry monitors outcomes to help healthcare professionals understand the drug's impact on pregnancy and infant health. Breastfeeding It is unknown if Fintepla passes into breast milk or if it could affect a breastfeeding child. If you are breastfeeding or planning to breastfeed, discuss your options with your doctor to determine the safest approach for you and your baby.

Q: What forms and strengths does Fintepla come in?

Fintepla is supplied in the following form: Oral solution: This is a liquid form of the medication that is swallowed. The oral solution is a clear, colorless liquid. It is typically administered using a specialized oral syringe to ensure the dose is measured correctly. It is important to use the measuring device provided with the medication rather than a household spoon.

Q: What is the FDA approval status of Fintepla?

FDA Approval and Indications Fintepla (fenfluramine) was first approved by the FDA in June 2020 for the treatment of seizures associated with Dravet syndrome. In March 2022, the FDA expanded its approved use to include the treatment of seizures associated with Lennox-Gastaut syndrome. It is indicated for use in pediatric and adult patients 2 years of age and older. Boxed Warning and Safety Risks The FDA has issued a Boxed Warning for Fintepla because of the risk of serious cardiovascular complications, specifically valvular heart disease and pulmonary arterial hypertension. Because of these risks, patients must undergo regular cardiac monitoring, including echocardiograms before starting treatment, every six months during treatment, and once six months after treatment has stopped. REMS Program Due to the risk of heart and lung complications, Fintepla is only available through a restricted distribution program called the FINTEPLA Risk Evaluation and Mitigation Strategy (REMS). Under this program: Prescribers and pharmacies must be certified with the REMS program to prescribe or dispense the medication. Patients must be enrolled in the program and comply with the required cardiac monitoring schedule. Controlled Substance Status Fintepla is classified as a Schedule IV controlled substance under the Controlled Substances Act. This classification is due to its potential for abuse and dependence, requiring healthcare providers to monitor patients for signs of misuse.

Question 1

What is Fintepla?

Accepted Answer

Fintepla is a prescription medication used to help manage and reduce the frequency of seizures. It belongs to a class of drugs that act on the central nervous system to stabilize electrical signaling in the brain.

The medication works by modulating the activity of certain natural chemicals that transmit messages between nerve cells. It is intended to be used as part of a comprehensive approach to seizure management.

Question 2

What is Fintepla used for?

Accepted Answer

Fintepla is used to treat Dravet syndrome and Lennox-Gastaut syndrome.

Question 3

How does Fintepla work?

Accepted Answer

Mechanism of Action

Fintepla belongs to a class of medications known as anticonvulsants. While the exact way it works to control seizures is not fully understood, researchers believe it primarily affects chemical signaling in the brain.

Serotonin Regulation

One of the main ways Fintepla is thought to work is by increasing the levels and activity of serotonin. Serotonin is a natural substance, or neurotransmitter, that helps brain cells communicate. Fintepla acts as a serotonin receptor agonist, which means it stimulates specific receptors in the brain that respond to serotonin. This increased activity is believed to help regulate the electrical signals that can lead to seizures.

Sigma-1 Receptors

In addition to its effects on serotonin, Fintepla may also interact with sigma-1 receptors. These receptors play a role in how nerve cells function and communicate with one another. By acting on these pathways, the medication helps stabilize brain activity.

By influencing these different chemical systems, Fintepla helps to decrease the frequency of seizures in people with certain types of epilepsy, such as Dravet syndrome and Lennox-Gastaut syndrome.

Question 4

What are the active ingredients in Fintepla?

Accepted Answer

The active ingredient in Fintepla is fenfluramine.

Question 5

What are the side effects of Fintepla?

Accepted Answer

Common side effects of Fintepla may include:

Decreased appetite
Diarrhea
Fatigue
and others.

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Fintepla?

Accepted Answer

Fintepla belongs to the serotonin releasing agent drug class.

Question 7

What is the dosage of Fintepla and how do I take it?

Accepted Answer

How to Take Fintepla

Fintepla is an oral solution that is usually taken twice a day. It can be taken with or without food.

Administration Instructions

Measuring the Dose: Always use the oral dosing syringe provided with the medication to ensure the dose is measured accurately. Do not use household spoons or other kitchen measuring tools, as they may not provide the correct amount.
Feeding Tubes: This medication can be administered through certain types of gastric or enteral feeding tubes. If using a tube, it should be flushed with water after the dose is given to ensure all the medicine has been delivered.
Consistency: Try to take the medication at the same times every day to maintain a steady level of the drug in the body.

Missed Doses

If a dose of Fintepla is missed, skip that dose and take the next dose at the regularly scheduled time. Do not take two doses at once to make up for a missed dose.

Question 8

Is Fintepla safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

The safety of Fintepla during pregnancy has not been established. While animal studies have suggested potential risks to a developing fetus, there is currently no adequate data on its effects in pregnant humans. Individuals who are pregnant or planning to become pregnant should consult their healthcare provider to weigh the potential benefits against the risks.

There is a pregnancy registry for people who take Fintepla during pregnancy. This registry monitors outcomes to help healthcare professionals understand the drug's impact on pregnancy and infant health.

Breastfeeding

It is unknown if Fintepla passes into breast milk or if it could affect a breastfeeding child. If you are breastfeeding or planning to breastfeed, discuss your options with your doctor to determine the safest approach for you and your baby.

Question 9

What forms and strengths does Fintepla come in?

Accepted Answer

Fintepla is supplied in the following form:

Oral solution: This is a liquid form of the medication that is swallowed.

The oral solution is a clear, colorless liquid. It is typically administered using a specialized oral syringe to ensure the dose is measured correctly. It is important to use the measuring device provided with the medication rather than a household spoon.

Question 10

What is the FDA approval status of Fintepla?

Accepted Answer

FDA Approval and Indications

Fintepla (fenfluramine) was first approved by the FDA in June 2020 for the treatment of seizures associated with Dravet syndrome. In March 2022, the FDA expanded its approved use to include the treatment of seizures associated with Lennox-Gastaut syndrome. It is indicated for use in pediatric and adult patients 2 years of age and older.

Boxed Warning and Safety Risks

The FDA has issued a Boxed Warning for Fintepla because of the risk of serious cardiovascular complications, specifically valvular heart disease and pulmonary arterial hypertension. Because of these risks, patients must undergo regular cardiac monitoring, including echocardiograms before starting treatment, every six months during treatment, and once six months after treatment has stopped.

REMS Program

Due to the risk of heart and lung complications, Fintepla is only available through a restricted distribution program called the FINTEPLA Risk Evaluation and Mitigation Strategy (REMS). Under this program:

Prescribers and pharmacies must be certified with the REMS program to prescribe or dispense the medication.
Patients must be enrolled in the program and comply with the required cardiac monitoring schedule.

Controlled Substance Status

Fintepla is classified as a Schedule IV controlled substance under the Controlled Substances Act. This classification is due to its potential for abuse and dependence, requiring healthcare providers to monitor patients for signs of misuse.

Question 11

What should I know about Fintepla and cost?

Accepted Answer

Brand-Name Status

Fintepla is a brand-name medication, and there is currently no generic version available. Brand-name drugs typically cost more than generics because they are protected by patents that prevent other companies from making the same medication for a set period.

Insurance Coverage

Most insurance plans, including private insurance and government programs like Medicare or Medicaid, may cover Fintepla. However, the out-of-pocket cost will vary based on your specific plan's formulary, your deductible, and your copayment or coinsurance requirements. Some insurance companies may require prior authorization before they agree to cover the medication.

Specialty Pharmacy and REMS

Fintepla is not available at most local retail pharmacies. It must be obtained through a restricted distribution program called the Fintepla REMS program. This means the drug is dispensed by authorized specialty pharmacies, which may have different billing processes than standard pharmacies.

Financial Assistance

The manufacturer of Fintepla offers support programs to help patients manage the cost of the drug. These may include:

Copay Savings Cards: These cards can help reduce out-of-pocket costs for patients with commercial (private) insurance.
Patient Assistance Programs: These programs may provide the medication at a lower cost or for free to individuals who are uninsured or underinsured and meet certain income requirements.

Fintepla

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Fintepla

Hospitals.net Disclosure